Description: Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It has developed a testing platform that produces COVID-19 single-use test kit with molecular accuracy. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.
Home Page: www.lucirahealth.com
LHDX Technical Analysis
1412 62nd Street
EmeryVille,
CA
94608
United States
Phone:
510 350 8071
Officers
| Name | Title |
|---|---|
| Mr. Erik T. Engelson | Pres, CEO & Director |
| Mr. Kevin Walter Collins | Chief Revenue Officer |
| Mr. Ghazi Kashmolah | Chief Quality Officer & Exec. VP of Regulatory Affairs |
| Mr. Richard Narido | Chief Financial Officer |
| Mr. Tony Allen | Chief Operations Officer |
| Greg Chodaczek | Investor Relations |
| Dr. Nadine Greiner Ph.D. | Chief HR Officer |
| Mr. Daniel V. George | Treasurer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.1901 |
| Price-to-Sales TTM: | 0.0392 |
| IPO Date: | 2021-02-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 221 |